Atlas Trials

Zenas BioPharma (USA), LLC

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zenas BioPharma (USA), LLC

RecordFirmDate
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis (NCT07067463)Zenas BioPharma (USA), LLC2026-03-23
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis (NCT07299019)Zenas BioPharma (USA), LLC2026-03-23
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus (NCT06559163)Zenas BioPharma (USA), LLC2024-09-17
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) (NCT06564311)Zenas BioPharma (USA), LLC2024-08-26
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) (NCT05786573)Zenas BioPharma (USA), LLC2023-09-25
A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants (NCT05794516)Zenas BioPharma (USA), LLC2023-06-19
Study of ZB001 in Chinese Patients With Thyroid Eye Disease (NCT05776121)Zenas BioPharma (USA), LLC2023-05-10
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease (NCT05662241)Zenas BioPharma (USA), LLC2023-01-09
A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis (NCT05638854)Zenas BioPharma (USA), LLC2022-12-08
A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects (NCT05542303)Zenas BioPharma (USA), LLC2022-10-16

Track Zenas BioPharma (USA), LLC automatically

Every clearance here is in the API, with alerts when new ones post.